C. Gonzalez-agosti

The TSC1 Tumor Suppressor Hamartin Interacts with Neurofilament-L and Possibly Functions as a Novel Integrator of the Neuronal Cytoskeleton*

Mark J. Bowser, Vijaya Ramesh, L. A. Haddad, 2002, The Journal of Biological Chemistry.

The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.

J. Hartwig, M. James, C. Gonzalez-agosti, 2001, The Biochemical journal.

NHE-RF, a Regulatory Cofactor for Na+-H+Exchange, Is a Common Interactor for Merlin and ERM (MERM) Proteins*

J. Gusella, C. Gonzalez-agosti, V. Ramesh, 1998, The Journal of Biological Chemistry.

The merlin tumor suppressor localizes preferentially in membrane ruffles.

J. Gusella, R. Beauchamp, C. Gonzalez-agosti, 1996, Oncogene.

Universal absence of merlin, but not other ERM family members, in schwannomas.

D. Louis, J. Gusella, A. Stemmer-Rachamimov, 1997, The American journal of pathology.

Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells.

R. Beauchamp, C. Gonzalez-agosti, V. Ramesh, 1998, Experimental cell research.

Response of radixin to perturbations of growth cone morphology and motility in chick sympathetic neurons in vitro.

C. Gonzalez-agosti, F. Solomon, C. Gonzalez-Agosti, 1996, Cell motility and the cytoskeleton.

Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer.

E. Chiocca, C. Gonzalez-agosti, V. Ramesh, 1999, Journal of neurosurgery.

Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells.

X. Breakefield, C. Gonzalez-agosti, V. Ramesh, 2000, Human molecular genetics.

Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.

A. Stemmer-Rachamimov, D. Louis, R. Beauchamp, 1997, Journal of neuropathology and experimental neurology.

Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology

R. Nitsch, C. Hock, A. Papassotiropoulos, 2004, Neurodegenerative Diseases.

Treatment with the selective muscarinic ml agonist talsaclidine decreases cerebrospinal fluid levels of Aβ42 in patients with Alzheimer's disease

W. Oertel, H. Hampel, R. Nitsch, 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Interdomain Interaction of Merlin Isoforms and Its Influence on Intermolecular Binding to NHE-RF*

C. Gonzalez-agosti, V. Ramesh, M. Herndon, 1999, The Journal of Biological Chemistry.